Cellectis SA (CLLS)
2.536
-0.02
(-0.94%)
USD |
NASDAQ |
May 01, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
Cellectis Enterprise Value: 12.27M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 12.27M |
| April 30, 2024 | 13.99M |
| April 29, 2024 | 13.99M |
| April 26, 2024 | 10.08M |
| April 25, 2024 | 8.955M |
| April 24, 2024 | 9.675M |
| April 23, 2024 | 18.29M |
| April 22, 2024 | 19.75M |
| April 19, 2024 | 13.27M |
| April 18, 2024 | 7.516M |
| April 17, 2024 | 6.797M |
| April 16, 2024 | 8.955M |
| April 15, 2024 | 17.59M |
| April 12, 2024 | 23.35M |
| April 11, 2024 | 31.26M |
| April 10, 2024 | 30.54M |
| April 09, 2024 | 27.66M |
| April 08, 2024 | 23.35M |
| April 05, 2024 | 22.63M |
| April 04, 2024 | 27.66M |
| April 03, 2024 | 30.54M |
| April 02, 2024 | 20.47M |
| April 01, 2024 | 12.55M |
| March 28, 2024 | 19.93M |
| March 27, 2024 | 21.37M |
| Date | Value |
|---|---|
| March 26, 2024 | 14.19M |
| March 25, 2024 | 14.91M |
| March 22, 2024 | 9.169M |
| March 21, 2024 | 11.32M |
| March 20, 2024 | 5.581M |
| March 19, 2024 | 2.711M |
| March 18, 2024 | 8.452M |
| March 15, 2024 | 12.04M |
| March 14, 2024 | 11.32M |
| March 13, 2024 | 13.47M |
| March 12, 2024 | 17.78M |
| March 11, 2024 | 4.146M |
| March 08, 2024 | 15.63M |
| March 07, 2024 | 9.886M |
| March 06, 2024 | 10.60M |
| March 05, 2024 | 7.734M |
| March 04, 2024 | 16.34M |
| March 01, 2024 | 19.93M |
| February 29, 2024 | 14.91M |
| February 28, 2024 | 12.33M |
| February 27, 2024 | 24.50M |
| February 26, 2024 | 24.50M |
| February 23, 2024 | 32.37M |
| February 22, 2024 | 38.10M |
| February 21, 2024 | 34.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.54M
Minimum
Jun 16 2022
1.203B
Maximum
Jan 19 2021
255.80M
Average
177.05M
Median
Sep 10 2019
Enterprise Value Benchmarks
| DBV Technologies SA | -12.56M |
| Genfit SA | 156.58M |
| Biophytis SA | 2.443M |
| Edap TMS SA | 223.52M |
| Biodexa Pharmaceuticals Plc | -1.818M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -42.86M |
| Revenue (Quarterly) | 0.283M |
| Total Expenses (Quarterly) | 29.86M |
| EPS Diluted (Quarterly) | -0.70 |
| Gross Profit Margin (Quarterly) | 40.99% |
| Profit Margin (Quarterly) | -15.15K% |
| Earnings Yield | -70.19% |
| Normalized Earnings Yield | -70.82 |